4.7 Article

IL-1β potently stabilizes IL-6 mRNA in human astrocytes

Journal

BIOCHEMICAL PHARMACOLOGY
Volume 81, Issue 8, Pages 1004-1015

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2011.01.019

Keywords

mRNA stability; IL-6; Astrocytes; IL-1 beta; PKC; p38

Funding

  1. Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)
  2. Ghent University GROUP-ID consortium
  3. Ghent University [BOF 01D31406]

Ask authors/readers for more resources

Uncontrolled expression of IL-6 in the central nervous system is associated with neurodegenerative pathology and glioma development. Astrocytes are the predominant source of IL-6 in the central nervous system, and they are characteristically susceptible to synergistic IL-6 expression. Combined beta-adrenergic and TNF-receptor triggering induces synergistic IL-6 expression in 1321N1 cells via a transcriptional enhancer mechanism. Here, we have investigated the molecular basis of the very potent super-synergistic IL-6 expression that is apparent after combined treatment of astrocytes with a beta-adrenergic agonist, isoproterenol, and the inflammatory cytokines TNF-alpha and IL-1 beta. We found that IL-1 beta treatment strengthens the IL-6 synergy by inducing a distinct stabilization of IL-6 mRNA. Surprisingly, the mRNA-stabilizing effect seems to be dependent on protein kinase C (PKC), but not on the prototypical mRNA-stabilizing kinase p38. Moreover, although the mRNA-binding protein HuR basally stabilizes IL-6 mRNA, the mRNA-stabilizing effect of IL-1 beta is independent of HuR. Our data using pharmacological inhibitors suggest PKC is an important modulator of IL-6 expression in the central nervous system and this might have therapeutic implications. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development

Anne-Catherine Dolens, Kaat Durinck, Marieke Lavaert, Joni Van der Meulen, Imke Velghe, Jelle De Medts, Karin Weening, Juliette Roels, Katrien De Mulder, Pieter-Jan Volders, Katleen De Preter, Tessa Kerre, Bart Vandekerckhove, Georges Leclercq, Jo Vandesompele, Pieter Mestdagh, Pieter Van Vlierberghe, Frank Speleman, Tom Taghon

EMBO REPORTS (2020)

Article Biochemistry & Molecular Biology

Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome

Ruben Van Paemel, Andries De Koker, Christa Caggiano, Annelien Morlion, Pieter Mestdagh, Bram De Wilde, Jo Vandesompele, Katleen De Preter

Summary: The study evaluated the impact of blood collection tube type and time delay on cfDNA methylation analysis, finding that all preservation tubes performed similarly on quality metrics. A significant increase in cfDNA concentration and the fraction derived from NK cells was observed after a 72-hour time delay in EDTA tubes.

EPIGENETICS (2021)

Article Oncology

Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Jingwei Chen, Christopher Nelson, Matthew Wong, Andrew E. Tee, Pei Y. Liu, Ting La, Jamie I. Fletcher, Alvin Kamili, Chelsea Mayoh, Christoph Bartenhagen, Toby N. Trahair, Ning Xu, Nisitha Jayatilleke, Marie Wong, Hui Peng, Bernard Atmadibrata, Belamy B. Cheung, Qing Lan, Tracy M. Bryan, Pieter Mestdagh, Jo Vandesompele, Valerie Combaret, Valentina Boeva, Jenny Y. Wang, Isabelle Janoueix-Lerosey, Mark J. Cowley, Karen L. MacKenzie, Alla Dolnikov, Jinyan Li, Patsie Polly, Glenn M. Marshall, Roger R. Reddel, Murray D. Norris, Michelle Haber, Matthias Fischer, Xu D. Zhang, Hilda A. Pickett, Tao Liu

Summary: The combination therapy of OTX015 and carfilzomib shows synergistic anticancer effects on TERT-rearranged neuroblastoma by reducing TERT expression, inducing cell apoptosis, and suppressing tumor progression. This treatment approach is likely to be translated into the first clinical trial of targeted therapy in patients with TERT-rearranged neuroblastoma.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions

Liselot M. Mus, Stephane Van Haver, Mina Popovic, Wim Trypsteen, Steve Lefever, Nadja Zeltner, Yudelca Ogando, Eva Z. Jacobs, Geertrui Denecker, Ellen Sanders, Christophe Van Neste, Suzanne Vanhauwaert, Bieke Decaesteker, Dieter Deforce, Filip Van Nieuwerburgh, Pieter Mestdagh, Jo Vandesompele, Bjorn Menten, Katleen De Preter, Lorenz Studer, Bjorn Heindryckx, Kaat Durinck, Stephen Roberts, Frank Speleman

Summary: Human embryonic stem cells and embryonal tumors both exhibit compromised G1/S checkpoint, leading to replicative stress and genomic instability. Long-term in vitro cultured hESCs show a high incidence of DNA copy number gains, which may provide a proliferative advantage.

GENES CHROMOSOMES & CANCER (2021)

Review Oncology

Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review

Eva Hulstaert, Annelien Morlion, Keren Levanon, Jo Vandesompele, Pieter Mestdagh

Summary: This systematic review presents 75 RNA biomarkers detectable in human biofluids for early diagnosis of ovarian cancer, with the majority identified using RT-qPCR or microarrays in blood-based fluids. Some studies utilized RNA-sequencing and looked into alternative fluids like urine and ascites. Promising biomarkers include miR-21, the miR-200 family, miR-205, miR-10a, and miR-346, while validation and further research are needed before clinical implementation. Challenges in biomarker validation and future perspectives are discussed to accelerate progress in this field.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer, Veerle Surmont, Annabel Meireson, Lieve Brochez, Dries Reynders, Els Goetghebeur, Robbe Van den Begin, Dirk Van Gestel, Vincent Renard, Piet Dirix, Pieter Mestdagh, Piet Ost

Summary: The CHEERS trial aims to evaluate whether concurrent administration of SBRT and CPIs can prolong progression-free survival in advanced solid tumor patients. This multicenter randomized phase II trial will assess the impact of SBRT on disease control time and explore outcomes such as survival, objective response, local control, quality of life, and toxicity in 98 patients.

BMC CANCER (2021)

Article Pathology

Evaluating Diagnostic Accuracy of Saliva Sampling Methods for Severe Acute Respiratory Syndrome Coronavirus 2 Reveals Differential Sensitivity and Association with Viral Load

Pieter Mestdagh, Michel Gillard, Sharonjit K. Dhillon, Jean-Paul Pirnay, Jeroen Poels, Jan Hellemans, Veronik Hutse, Celine Vermeiren, Maxime Boutier, Veerle De Wever, Patrick Soentjens, Sarah Djebara, Hugues Malonne, Emmanuel Andre, Marc Arbyn, John Smeraglia, Jo Vandesompele

Summary: Saliva specimens have lower sensitivity in detecting SARS-CoV-2 compared to nasopharyngeal swabs, but show higher sensitivity for cases with medium to high viral loads, potentially aiding in the identification of the most contagious cases.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

Correction Biotechnology & Applied Microbiology

The RNA Atlas expands the catalog of human non-coding RNAs (June, 10.1038/s41587-021-00936-1, 2021)

Lucia Lorenzi, Hua-Sheng Chiu, Francisco Avila Cobos, Stephen Gross, Pieter-Jan Volders, Robrecht Cannoodt, Justine Nuytens, Katrien Vanderheyden, Jasper Anckaert, Steve Lefever, Aidan P. Tay, Eric J. de Bony, Wim Trypsteen, Fien Gysens, Marieke Vromman, Tine Goovaerts, Thomas Birkballe Hansen, Scott Kuersten, Nele Nijs, Tom Taghon, Karim Vermaelen, Ken R. Bracke, Yvan Saeys, Tim De Meyer, Nandan P. Deshpande, Govardhan Anande, Ting-Wen Chen, Marc R. Wilkins, Ashwin Unnikrishnan, Katleen De Preter, Jorgen Kjems, Jan Koster, Gary P. Schroth, Jo Vandesompele, Pavel Sumazin, Pieter Mestdagh

NATURE BIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

The RNA Atlas expands the catalog of human non-coding RNAs

Lucia Lorenzi, Hua-Sheng Chiu, Francisco Avila Cobos, Stephen Gross, Pieter-Jan Volders, Robrecht Cannoodt, Justine Nuytens, Katrien Vanderheyden, Jasper Anckaert, Steve Lefever, Aidan P. Tay, Eric J. de Bony, Wim Trypsteen, Fien Gysens, Marieke Vromman, Tine Goovaerts, Thomas Birkballe Hansen, Scott Kuersten, Nele Nijs, Tom Taghon, Karim Vermaelen, Ken R. Bracke, Yvan Saeys, Tim De Meyer, Nandan P. Deshpande, Govardhan Anande, Ting-Wen Chen, Marc R. Wilkins, Ashwin Unnikrishnan, Katleen De Preter, Jorgen Kjems, Jan Koster, Gary P. Schroth, Jo Vandesompele, Pavel Sumazin, Pieter Mestdagh

Summary: The study identified numerous novel non-coding RNAs from 300 human tissues and cell lines, expanding the existing catalog of ncRNAs. By analyzing pre-mRNA abundance estimates from total RNA sequencing, the research revealed several microRNAs and long non-coding RNAs with potential roles in regulating protein-coding genes and pathways.

NATURE BIOTECHNOLOGY (2021)

Article Biochemistry & Molecular Biology

The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival

Shanna Dewaele, Louis Delhaye, Boel De Paepe, Eric James de Bony, Jilke De Wilde, Katrien Vanderheyden, Jasper Anckaert, Nurten Yigit, Justine Nuytens, Eveline Vanden Eynde, Joel Smet, Maxime Verschoore, Fariba Nemati, Didier Decaudin, Manuel Rodrigues, Peihua Zhao, Aart Jochemsen, Eleonora Leucci, Jo Vandesompele, Jo Van Dorpe, Jean-Christophe Marine, Rudy Van Coster, Sven Eyckerman, Pieter Mestdagh

Summary: The inhibition of SAMMSON in uveal melanoma cells has shown to impair cell growth and viability, induce apoptosis, and affect protein translation levels, highlighting its potential as a therapeutic target. This study demonstrates the essential role of SAMMSON expression in uveal melanoma cell survival, suggesting ASO-mediated silencing of SAMMSON as a promising treatment strategy for both primary and metastatic uveal melanoma patients.

ONCOGENE (2022)

Article Biochemistry & Molecular Biology

Custom long non-coding RNA capture enhances detection sensitivity in different human sample types

Annelien Morlion, Celine Everaert, Justine Nuytens, Eva Hulstaert, Jo Vandesompele, Pieter Mestdagh

Summary: Long non-coding RNAs (lncRNAs) are transcripts without protein coding potential that play regulatory roles in cellular processes. They have emerged as potential diagnostic and therapeutic targets, and a custom lncRNA capture sequencing approach allows for more accurate detection and higher coverage compared to traditional methods.

RNA BIOLOGY (2021)

Article Cell Biology

The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts

Geert A. Martens, Geert Stange, Lorenzo Piemonti, Jasper Anckaert, Zhidong Ling, Daniel G. Pipeleers, Frans K. Gorus, Pieter Mestdagh, Dieter De Smet, Jo Vandesompele, Bart Keymeulen, Sarah Roels

Summary: This study identified multiple beta cell-enriched microRNAs that are co-released with miR-375 and can be used as complementary biomarkers of beta cell death, with miR-375 and miR-132 showing potential for graft outcome.

CELLS (2021)

Article Cell Biology

Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions

Glenn Vergauwen, Joeri Tulkens, Claudio Pinheiro, Francisco Avila Cobos, Sandor Dedeyne, Marie-Angelique De Scheerder, Linos Vandekerckhove, Francis Impens, Ilkka Miinalainen, Geert Braems, Kris Gevaert, Pieter Mestdagh, Jo Vandesompele, Hannelore Denys, Olivier De Wever, An Hendrix

Summary: This study fractionated blood plasma using SEC and OptiPrep density gradient centrifugation to investigate clinical and time-dependent variations in the biomolecular landscape of systemically circulating EV. Results showed that EV carry context-dependent and/or time-dependent protein and small RNA compositions, with differential analysis providing a catalogue of proteins not associated with EV. Overall, blood plasma fractionation can advance the biological understanding and biomarker development of systemically circulating EV.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Biochemical Research Methods

Protocol Messenger RNA capture sequencing of extracellular RNA from human biofluids using a comprehensive set of spike-in controls

Eva Hulstaert, Anneleen Decock, Annelien Morlion, Celine Everaert, Kimberly Verniers, Justine Nuytens, Nele Nijs, Gary P. Schroth, Scott Kuersten, Stephen M. Gross, Pieter Mestdagh, Jo Vandesompele

Summary: The optimized workflow described in this study addresses the challenges of analyzing extracellular RNA (exRNA) from human biofluids with low RNA concentration and compromised integrity. It includes synthetic spike-in RNA molecules as processing controls and an alternative data normalization strategy.

STAR PROTOCOLS (2021)

Article Biochemistry & Molecular Biology

RNAcentral 2021: secondary structure integration, improved sequence search and new member databases

Blake A. Sweeney, Anton Petrov, Carlos E. Ribas, Robert D. Finn, Alex Bateman, Maciej Szymanski, Wojciech M. Karlowski, Stefan E. Seemann, Jan Gorodkin, Jamie J. Cannone, Robin R. Gutell, Simon Kay, Steven Marygold, Gil dos Santos, Adam Frankish, Jonathan M. Mudge, Ruth Barshir, Simon Fishilevich, Patricia P. Chan, Todd M. Lowe, Ruth Seal, Elspeth Bruford, Simona Panni, Pablo Porras, Dimitra Karagkouni, Artemis G. Hatzigeorgiou, Lina Ma, Zhang Zhang, Pieter-Jan Volders, Pieter Mestdagh, Sam Griffiths-Jones, Bastian Fromm, Kevin J. Peterson, Ioanna Kalvari, Eric P. Nawrocki, Anton S. Petrov, Shuai Weng, Philia Bouchard-Bourelle, Michelle Scott, Lauren M. Lui, David Hoksza, Ruth C. Lovering, Barbara Kramarz, Prita Mani, Sridhar Ramachandran, Zasha Weinberg

Summary: RNAcentral is a comprehensive database of non-coding RNA sequences, providing a single access point to over 18 million ncRNA sequences from diverse organisms and RNA types, as well as information on the secondary structure for over 13 million sequences. The database also includes a fast sequence similarity search tool with filtering options, making it a central data resource for the RNA community.

NUCLEIC ACIDS RESEARCH (2021)

Article Pharmacology & Pharmacy

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Ali, Alessandra Ottani, Eleonora Vandini, Patrizia Guidi, Margherita Bernardeschi, Veronica La Rocca, Giulio Francia, Gabriella Fontanini, Mauro Pistello, Giada Frenzilli, Daniela Giuliani, Marco Scarselli, Guido Bocci

Summary: This study investigates the role of MC4R in melanoma and the use of the selective antagonist ML in combination with vemurafenib. The results show that ML can inhibit melanoma cell proliferation and induce apoptosis through the inhibition of ERK1/2 phosphorylation and reduction of BCL-XL expression. The combination of vemurafenib and ML exhibits a synergistic effect in vitro and inhibits tumor growth in vivo without causing adverse effects.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Cardiac human bitter taste receptors contain naturally occurring variants that alter function

Conor J. Bloxham, Katina D. Hulme, Fabrizio Fierro, Christian Fercher, Cassandra L. Pegg, Shannon L. O'Brien, Simon R. Foster, Kirsty R. Short, Sebastian G. B. Furness, Melissa E. Reichelt, Masha Y. Niv, Walter G. Thomas

Summary: Bitter taste receptors (T2Rs) are a type of G protein-coupled receptors that allow humans to detect aversive and toxic substances. This study characterized the functional properties of previously identified T2Rs in human cardiac tissues and their naturally occurring polymorphisms. The results showed differences in signaling among different T2R variants, and revealed a potential association between the T2R50 Tyr203 variant and cardiovascular disease.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma

Lu Chen, Huanying Shi, Wenxin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang, Qunyi Li

Summary: This study demonstrates that Carfilzomib exhibits potent anti-tumor activity against esophageal squamous cell carcinoma (ESCC) by triggering mitochondrial apoptosis and reprogramming cellular metabolism. It has been identified that activating transcription factor 3 (ATF3) plays a crucial role as a cellular target in ESCC cells treated with Carfilzomib. Overexpression of ATF3 effectively counteracts the effects of Carfilzomib on ESCC cell proliferation, apoptosis, and metabolic reprogramming. Furthermore, ATF3 mediates the anti-tumor activity of Carfilzomib, suggesting its potential as a therapeutic agent for ESCC.

BIOCHEMICAL PHARMACOLOGY (2024)

Review Pharmacology & Pharmacy

Ferroptosis resistance in cancer: recent advances and future perspectives

Xing Zhang, Xiang Li, Ran Xia, Hong-Sheng Zhang

Summary: This review summarizes recent progress on the mechanisms of ferroptosis resistance in cancer and highlights the role of redox status and metabolism. Combination therapy for ferroptosis has great potential in treating resistant malignant tumors.

BIOCHEMICAL PHARMACOLOGY (2024)